From: Injectable hydrogels delivering therapeutic agents for disease treatment and tissue engineering
Injectable Hydrogel Systems | Crosslinking Reactions/Interactions | Applications (therapeutic agents) | Notes | References |
---|---|---|---|---|
Agar | ||||
Agar/MBP | PC, HB/ | Delivery of TD (DOX), chemotherapy for colon cancer, photothermal treatment by MBP | Temperature-sensitive release, temperature changed by MBP (a photoabsorbent) | [37] |
Alginate | ||||
Alginate-Ca | PC, EI/ | Delivery of TD (MX) and TPs (SDF-1α and pDNA), breast cancer therapy | Self-healing, the release and therapeutic efficacy regulated by pulsatile ultrasound | [38] |
OAlg/CMCS with GMs-TH | CC, SBR/ | Bacterial infection therapy | Antibacterial and biodegradable properties | [52] |
Chitosan | ||||
Chitosan/gelatin/polydopamine | PC, EI/ MR, SBR, | Parkinson’s disease therapy, TD delivery (MT) | Mechanical strength improved via EI | [20] |
Chitosan/gelatin/NDs | PC, EI, HB, VDWF/HB, DDI, HP | Scaffold for TE (embedded cell: VEGF) | Thermosensitive gelation, mechanical features improved by NDs, sustained release | [30] |
Chitosan-polyaniline/oxidized dextran | CC, SBR/ | Delivery of TDs (Amoxicillin and ibuprofen) | pH- and electric field- responsive, antibacterial activity | [33] |
CEC/OSA | CC, MR/ | TAD | Self-assembling, self-healing | [49] |
GC/poly(EO-co-Gly)-CHO | CC, SBR/ | Scaffold for TE (embedded cell: chondrocyte), cartilage repair | Mechanical properties and morphology controlled by poly(EO-co-Gly)-CHO | [51] |
Chondroitin Sulfate (ChS) | ||||
Pluronic F127-ChS/PEG | CC, DACR/ | Scaffold for TE (embedded cell: BMP-4), bone defect repair | Gelation of Pluronic F127-ChS at 37 oC, dual crosslinked Pluronic F127-ChS/PEG hydrogels | [44] |
Collagen | ||||
Collagen/Au | PC, EI/ | PTT, PDT, TAD (TMPyP), breast cancer therapy | Shear-thinning, self-healing, antitumor efficacy affected by light irradiation | [21] |
Collagen | PC, EI/ | Scaffold for TE (embedded cell: osteoblast (OB)), bone repair | Successful bone tissue regeneration by OB and LIPUS | [39] |
Dextrin | ||||
CD/PEG-phospholipid/Fe3O4 | PC, HI/ | Hyperthermia cancer therapy, chemotherapy for preventing breast cancer recurrence, delivery of TDs (PTX, DOX) | PTX and DOX Released by ACMF induced heat | [34] |
Gelatin | ||||
Gelatin MPs | PC, EI/ | Scaffold for TE (embedded TPs: VEGF and BMP2) | Release controlled by hydrogel degradation induced by CLSPA collagenase | [40] |
Gelatin-tetrazine fg/Gelatin- norbornene fg | CC, DACR/ | Scaffold for TE | Cell-compatible and enzymatically degradable properties | [43] |
Hyaluronic acid (HA) | ||||
HA-CD/ HA-AD, and HA-CD-MA/HA-AD-MA | PC, HGI, CC/ | Delivery of TP (EPC), vascular regeneration | Shear-thinning, self-healing | [28] |
HA-HMDA-cytosine/HA-HMDA-guanosine | PC, HB/ | Delivery of TP (BSA), scaffold for TE | pH-sensitive and self-healing, gelation only at pH 6-8 | [32] |
HAMC | PC, EI, HB/ | Delivery of TPs (RSCs, NSCs), retina and brain tissue therapy, scaffold for TE | Biodegradable and light-sensitive, HAMC-CD44 interaction | [35] |
HA-Heparin (HA-HP) | CC, PIC/ | Delivery of TP (AFS), wound healing | Crosslinking by UV light | [56] |
HA-Tyr | CC, EMCR, OCR/ | Scaffold for TE (embedded cell: hESC) | Highest hESC proliferation at HA-Tyr hydrogels with modulus of 350 Pa | [59] |
Peptide/protein | ||||
P1 | PC, PI, HP/ | Delivery of TDs (vitamin B12 and vancomycin, an antibiotic) | Thixotropic behavior at physiological condition | [23] |
FGd/Ag | PC, PI/ | Antimicrobial treatment with Ag | Mechanical stability for six months, high antimicrobial activity | [24] |
PA | PC, HI, HB, EI/ | Chemotherapy, delivery of TD (DOX) | PA concentration-dependent release behavior | [25] |
Peptide/catalase/glucose oxidase | PC, EI/ | Diabetic therapy, delivery of TP (insulin) | pH- and glucose-sensitive, self-assembling | [31] |
Multi-domain peptides (MDPs) nanofiber/liposome NPs | PS, HB, HI/ | Delivery of TPs (EGF, PlGF-1, MCP-1), Scaffold for TE | Release regulated via the hydrogel degradation by enzyme-mediation and the physical gelation by self-assembly | [41] |
Protein and Protein-GOX-CAT (PGT) | CC, EMCR/ | Scaffold for TE | Reversible self-healing, enzyme (glucose) mediated crosslinking by dynamic covalent interaction, 100% recovery PGT | [58] |
PCL | ||||
PEG-PCL-PEG | PC, HI/ | Chemotherapy including diabetic treatment, delivery of TP (insulin) | Sol-gel transition at 37 oC, lower viscosity than Pluronic®, Fickian release | [26] |
PEG | ||||
Polyamine-PEG-polyamine | PC, CC, EI, HB, PI/ | Delivery of TPs (insulin, BSA, glucose, avidin, neutravidin, or IL-12) | Self-assembling at 30 oC | [19] |
PLga-PEG-PLga -chol fg/ PLga-CD fg | PC, HGI/ | Scaffold for TE | Self-healing, self-assembling, properties regulated by the ratio of CD/Chol, high storage modulus | [27] |
PCLA-PEG-PCLA/heparin | PC, HI, CC, MR/EI | Delivery of TP (lysozyme), immunotherapy | Thermosensitive gelation at BT, sustained release | [29] |
PEG- aryl thiol fg/PEG-maleimide fg (or heparin-maleimide fg) | CC, MR/RLI | Delivery of TPs (FGF-2, cytokines, and immunomodulatory agents) | Light-and reducing environment- sensitive release | [36] |
PEG/TMVCyss and PEG/wt-TMV | CC, MR and PC/ | Scaffold for TE | TMV with multi-functionality, storage moduli improved by adding TMVCyss. No effect of wt-TMV on storage moduli | [48] |
PEG/PPLL | CC, SBR/ | Delivery of TDs (ME and 5FC), colon cancer therapy | Degradation and release controlled by pHs | [53] |
Polyoxamine | ||||
Polyoxamine-maleimide fg/ Polyoxamine-furyl fg | PC, CC, HI, DACR/ | Delivery of TP (bevacizumab, an antibody), colon, lung, and breast cancer therapy | Physical and chemical crosslinking, triphasic release controlled by two polyoxamines | [45] |
PVA | ||||
PVA-Tyr and PVA-Tyr-sericin-gelatin (PVA-SG) | CC, PIC/ | Scaffold for TE (embedded TP: Schwann) | Crosslinking by visible light, PVA-Tyr: no cell adhesion, PVA-SG: cell adhesion | [55] |
PNIPAAm | ||||
PNIPAAm/CNC | PC, VDWF, HB/ | Delivery of TD (MT), wound dressing | Volume transition at 36-39 oC, Mechanical strength increased by CNC | [22] |